Nathan O. Fuller

729 total citations
18 papers, 330 citations indexed

About

Nathan O. Fuller is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Nathan O. Fuller has authored 18 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Organic Chemistry and 6 papers in Physiology. Recurrent topics in Nathan O. Fuller's work include Alzheimer's disease research and treatments (5 papers), Advanced Synthetic Organic Chemistry (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Nathan O. Fuller is often cited by papers focused on Alzheimer's disease research and treatments (5 papers), Advanced Synthetic Organic Chemistry (4 papers) and Asymmetric Synthesis and Catalysis (4 papers). Nathan O. Fuller collaborates with scholars based in United States, Sweden and United Kingdom. Nathan O. Fuller's co-authors include James P. Morken, Timothy D. McKee, Jed L. Hubbs, Brian S. Bronk, Robyn Loureiro, Barbara Tate, Steven J. Taylor, Albert E. Russell, Ruichao Shen and Jeffrey L. Ives and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Tetrahedron Letters.

In The Last Decade

Nathan O. Fuller

18 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan O. Fuller United States	10	161	121	78	60	55	18	330
Gregory R. Luedtke United States	11	158 1.0×	253 2.1×	54 0.7×	48 0.8×	37 0.7×	15	425
Thomas A. Dineen United States	9	173 1.1×	302 2.5×	49 0.6×	86 1.4×	57 1.0×	12	397
Michael J. Ashton United Kingdom	11	236 1.5×	135 1.1×	57 0.7×	81 1.4×	34 0.6×	19	409
Paul A. Tuthill United States	9	167 1.0×	149 1.2×	55 0.7×	54 0.9×	24 0.4×	14	371
Hongchan An South Korea	14	228 1.4×	180 1.5×	34 0.4×	57 0.9×	18 0.3×	35	482
Matthew M. Weiss United States	10	141 0.9×	527 4.4×	45 0.6×	74 1.2×	35 0.6×	22	676
Yuli Xie United States	14	241 1.5×	150 1.2×	47 0.6×	47 0.8×	16 0.3×	26	486
Alan M. Birch United Kingdom	11	165 1.0×	191 1.6×	42 0.5×	32 0.5×	33 0.6×	20	402
Babu Mavunkel United States	12	153 1.0×	204 1.7×	60 0.8×	44 0.7×	48 0.9×	22	384
L Rondahl Sweden	6	225 1.4×	79 0.7×	38 0.5×	62 1.0×	28 0.5×	8	377

Countries citing papers authored by Nathan O. Fuller

Since Specialization

Citations

This map shows the geographic impact of Nathan O. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan O. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan O. Fuller more than expected).

Fields of papers citing papers by Nathan O. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan O. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan O. Fuller. The network helps show where Nathan O. Fuller may publish in the future.

Co-authorship network of co-authors of Nathan O. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan O. Fuller. A scholar is included among the top collaborators of Nathan O. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan O. Fuller. Nathan O. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Fuller, Nathan O., Antonella Pirone, Berkley A. Lynch, et al.. (2018). CoREST Complex-Selective Histone Deacetylase Inhibitors Show Prosynaptic Effects and an Improved Safety Profile To Enable Treatment of Synaptopathies. ACS Chemical Neuroscience. 10(3). 1729–1743. 39 indexed citations

Fuller, Nathan O., Loredana Spadola, Scott D. Cowen, et al.. (2016). An improved model for fragment-based lead generation at AstraZeneca. Drug Discovery Today. 21(8). 1272–1283. 58 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2015). Minimization of drug–drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators. Bioorganic & Medicinal Chemistry Letters. 25(7). 1621–1626. 6 indexed citations

Shen, Ruichao, Nathan O. Fuller, Jed L. Hubbs, et al.. (2014). Multikilogram-Scale Production of Cycloartenol Triterpenoid Glycosides as Synthetic Intermediates for a γ-Secretase Modulator. Organic Process Research & Development. 18(6). 676–682. 3 indexed citations

Fuller, Nathan O., et al.. (2014). Optimization of a Kilogram-Scale Synthesis of a Potent Cycloartenol Triterpenoid-Derived γ-Secretase Modulator. Organic Process Research & Development. 18(6). 683–692. 4 indexed citations

Loureiro, Robyn, Jo Ann Dumin, Timothy D. McKee, et al.. (2013). Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models. Alzheimer s Research & Therapy. 5(2). 19–19. 20 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Steffen P. Creaser, et al.. (2013). SAR investigations on a novel class of gamma-secretase modulators based on a unique scaffold. MedChemComm. 4(3). 569–569. 8 indexed citations

Hubbs, Jed L., Nathan O. Fuller, Ruichao Shen, et al.. (2012). Optimization of a Natural Product-Based Class of γ-Secretase Modulators. Journal of Medicinal Chemistry. 55(21). 9270–9282. 38 indexed citations

Tate, Barbara, Timothy D. McKee, Robyn Loureiro, et al.. (2012). Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease. International Journal of Alzheimer s Disease. 2012. 1–10. 20 indexed citations

10.

Fuller, Nathan O., Jed L. Hubbs, Steffen P. Creaser, et al.. (2012). Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside. ACS Medicinal Chemistry Letters. 3(11). 908–913. 18 indexed citations

11.

Loureiro, Robyn, Timothy D. McKee, Jo Ann Dumin, et al.. (2012). O1‐11‐01: Satori gamma‐secretase modulators are efficacious in wild‐type rodents following either acute or steady‐state dosing. Alzheimer s & Dementia. 8(4S_Part_3). 1 indexed citations

12.

Fuller, Nathan O., et al.. (2011). Toward a total synthesis of the stemofoline alkaloids: advancement of a 1,3-dipolar cycloaddition strategy. Tetrahedron Letters. 52(32). 4076–4079. 17 indexed citations

13.

Xia, Weiming, Timothy D. McKee, Robyn Loureiro, et al.. (2011). P2‐513: Classification of γ‐secretase modulators and their effect on pharmacological profiles of amyloid β peptides. Alzheimer s & Dementia. 7(4S_Part_14). 1 indexed citations

14.

Li, Wei, Jianchang Li, Luca F. Raveglia, et al.. (2009). Identification of an Orally Efficacious Matrix Metalloprotease 12 Inhibitor for Potential Treatment of Asthma. Journal of Medicinal Chemistry. 52(17). 5408–5419. 33 indexed citations

15.

Fuller, Nathan O. & James P. Morken. (2005). Direct Formation of Synthetically Useful Silyl‐Protected Aldol Adducts via the Asymmetric Reductive Aldol Reaction.. ChemInform. 36(41). 1 indexed citations

16.

Morken, James P. & Nathan O. Fuller. (2005). Direct Formation of Synthetically Useful Silyl-Protected Aldol Adducts via the Asymmetric Reductive Aldol Reaction. Synlett. 1459–1461. 2 indexed citations

17.

Fuller, Nathan O. & James P. Morken. (2005). Studies on the Synthesis of the Inostamycin Natural Products: A Reductive Aldol/Reductive Claisen Approach to the C₁₀−C₂₄ Ketone Fragment. Organic Letters. 7(22). 4867–4869. 14 indexed citations

18.

Russell, Albert E., et al.. (2004). Investigation of the Rh-Catalyzed Asymmetric Reductive Aldol Reaction. Expanded Scope Based on Reaction Analysis. Organic Letters. 6(14). 2309–2312. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact